Ex Vivo Innate Immune Cytokine Signature of Enhanced Risk of Relapsing Brucellosis

Abstract

This work demonstrates that informative cytokine variations in brucellosis patients can be detected using an ex vivo assay system and used to identify patients with differing infection histories. Targeted diagnosis of this signature may allow for better follow-up care of brucellosis patients through improved identification of patients at risk for relapse.